Literature DB >> 17721435

Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state.

Kelly A Green1, Jason S Carroll.   

Abstract

Oestrogen receptor-alpha (ERalpha)-regulated transcription in breast cancer cells involves protein co-factors that contribute to the regulation of chromatin structure. These include co-factors with the potential to regulate histone modifications such as acetylation or methylation, and therefore the transcriptional state of target genes. Although much of the information regarding the interaction of specific co-factors with ER has been generated by studying specific promoter regions, we now have an improved understanding of the nature of these interactions and are better placed to relate these with ER activity and potentially with the activity of breast cancer drugs, including tamoxifen.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17721435     DOI: 10.1038/nrc2211

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  113 in total

1.  Determination of transcription factor binding.

Authors:  Edwin Cheung; Yijun Ruan
Journal:  Nat Genet       Date:  2011-01       Impact factor: 38.330

2.  Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism.

Authors:  Ty C Voss; R Louis Schiltz; Myong-Hee Sung; Paul M Yen; John A Stamatoyannopoulos; Simon C Biddie; Thomas A Johnson; Tina B Miranda; Sam John; Gordon L Hager
Journal:  Cell       Date:  2011-08-11       Impact factor: 41.582

3.  Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells.

Authors:  Surojeet Sengupta; Rachel Schiff; Benita S Katzenellenbogen
Journal:  Breast Cancer Res Treat       Date:  2008-09-19       Impact factor: 4.872

4.  Proteomics analysis of the estrogen receptor alpha receptosome.

Authors:  Ivan Nalvarte; Thomas Schwend; Jan-Ake Gustafsson
Journal:  Mol Cell Proteomics       Date:  2010-03-27       Impact factor: 5.911

5.  Histone deacetylation during brain development is essential for permanent masculinization of sexual behavior.

Authors:  Ken Ichi Matsuda; Hiroko Mori; Bridget M Nugent; Donald W Pfaff; Margaret M McCarthy; Mitsuhiro Kawata
Journal:  Endocrinology       Date:  2011-05-17       Impact factor: 4.736

6.  Differential estradiol and selective estrogen receptor modulator (SERM) regulation of Keratin 13 gene expression and its underlying mechanism in breast cancer cells.

Authors:  Shubin Sheng; Daniel H Barnett; Benita S Katzenellenbogen
Journal:  Mol Cell Endocrinol       Date:  2008-10-04       Impact factor: 4.102

Review 7.  PELP1: A novel therapeutic target for hormonal cancers.

Authors:  Dimple Chakravarty; Rajeshwar Rao Tekmal; Ratna K Vadlamudi
Journal:  IUBMB Life       Date:  2010-03       Impact factor: 3.885

8.  Histone H2A.Z is essential for estrogen receptor signaling.

Authors:  Nicolas Gévry; Sara Hardy; Pierre-Etienne Jacques; Liette Laflamme; Amy Svotelis; François Robert; Luc Gaudreau
Journal:  Genes Dev       Date:  2009-06-10       Impact factor: 11.361

9.  Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.

Authors:  L Hao; P Rizzo; C Osipo; A Pannuti; D Wyatt; L W-K Cheung; G Sonenshein; B A Osborne; L Miele
Journal:  Oncogene       Date:  2009-10-19       Impact factor: 9.867

10.  Estrogen receptor alpha represses transcription of early target genes via p300 and CtBP1.

Authors:  Fabio Stossi; Zeynep Madak-Erdogan; Benita S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.